coronavirus
Commission puts forward a revised export transparency and authorization mechanism and measures for accelerated approval of adapted vaccines against COVID-19 variants
The European Commission has introduced the principles of reciprocity and proportionality as new criteria to be considered for authorizing exports under the transparency and authorisation mechanism for COVID-19 vaccine exports. This system has significantly improved the transparency of exports. Nevertheless, the objective to ensure timely access to COVID-19 vaccines for EU citizens is still not met. A press release is available online.
Also, as an immediate action under the HERA Incubator, the new European bio-defence preparedness plan against COVID-19 variants, the Commission is introducing a measure to speed up the authorisation of adapted COVID-19 vaccines. It will make provisions in the relevant EU legislation to allow companies to focus on gathering the necessary evidence in time and enable the authorisation of adapted vaccines with a smaller set of additional data submitted to the European Medicines Agency. A press release is available here.
You can follow the press conference by Executive Vice-President Valdis Dombrovskis and Commissioner Stella Kyriakides on EbS.
Share this article:
-
Motoring4 days ago
Fiat 500 vs. Mini Cooper: A Detailed Comparison
-
Horizon Europe4 days ago
Swansea academics awarded €480,000 Horizon Europe grant to support new research and innovation project
-
Lifestyle4 days ago
Transforming Your Living Room: A Glimpse into the Future of Entertainment Tech
-
Bahamas4 days ago
Bahamas files Legal Submissions on Climate Change with International Court of Justice